NFA
GNMK

Nationwide Fund Advisors’s GenMark Diagnostics, Inc GNMK Stock Holding History

Nationwide Fund Advisors’s Portfolio GNMK Stock Details GNMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-28,322
Closed -$273K – 2589
2017
Q3 		$273K Buy
28,322
+3,483
+14% +$36.2K ﹤0.01% 2484
2017
Q2 		$294K Sell
24,839
-1,097
-4% -$14K ﹤0.01% 2454
2017
Q1 		$332K Buy
25,936
+981
+4% +$11.8K ﹤0.01% 2368
2016
Q4 		$305K Sell
24,955
-1,157
-4% -$13.7K ﹤0.01% 2424
2016
Q3 		$308K Hold
26,112
– – ﹤0.01% 2417
2016
Q2 		$227K Sell
26,112
-1,492
-5% -$10.2K ﹤0.01% 2548
2016
Q1 		$145K Hold
27,604
– – ﹤0.01% 2675
2015
Q4 		$214K Buy
27,604
+535
+2% +$4.11K ﹤0.01% 2515
2015
Q3 		$213K Hold
27,069
– – ﹤0.01% 2531
2015
Q2 		$245K Sell
27,069
-3,487
-11% -$35.2K ﹤0.01% 2600
2015
Q1 		$397K Sell
30,556
-1,227
-4% -$16K ﹤0.01% 2357
2014
Q4 		$433K Sell
31,783
-186
-0.6% -$2.08K ﹤0.01% 2265
2014
Q3 		$287K Buy
31,969
+259
+0.8% +$2.79K ﹤0.01% 2521
2014
Q2 		$429K Buy
31,710
+4,062
+15% +$42.4K ﹤0.01% 2348
2014
Q1 		$275K Hold
27,648
– – ﹤0.01% 2345
2013
Q4 		$368K Sell
27,648
-915
-3% -$11.1K ﹤0.01% 2379
2013
Q3 		$347K Buy
28,563
+19,256
+207% +$206K ﹤0.01% 2395
2013
Q2 		$96K Buy
+9,307
New +$128K ﹤0.01% 2819

Other funds holding GNMK

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Nationwide Fund Advisors's GNMK Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of GenMark Diagnostics, Inc (GNMK) in Q4 2017, closing a stake of 28,322 shares — an estimated $273K sold.

Nationwide Fund Advisors first reported a position in GNMK in Q2 2013 and held it in 18 quarters. The position peaked at $433K in Q4 2014. 99 funds tracked by Wall St. Rank hold GNMK as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining GenMark Diagnostics, Inc position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 28,322 GenMark Diagnostics, Inc shares in Q4 2017, an estimated $273K.
  • Nationwide Fund Advisors first reported a position in GenMark Diagnostics, Inc in Q2 2013 and held it in 18 quarters.
  • Nationwide Fund Advisors's GenMark Diagnostics, Inc position peaked at $433K in Q4 2014.
  • 99 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.